Our Clients
While the needs of each client differ, the fundamentals of creative conception, strategic planning, professional execution and results that return the client’s investment define every project. This commitment is underscored not only by the number of companies which MCS has supported since 1985, but also by the long tenure of our relationships with many of these clients.
 |
Adams Respiratory Therapeutics |
|
 |
Auxilium Pharmaceuticals |
|
 |
BD |
|
 |
CSL Behring |
|
 |
Genentech |
|
 |
Qforma |
|
 |
Regeneron Pharmaceuticals |
|
 |
 |
Schering-Plough |
 |
Synergetics USA |
Schering-Plough
Profile
MCS provides communication support to Schering-Plough's INTEGRILIN® (eptifibatide) Injection for acute coronary syndrome, and international communication support for REMICADE® for the treatment of Crohn's disease, ulcerative colitis, inflammatory bowel disease, psoriasis, psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis.
Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its more than 32,000 people around the world.
For more information on Schering-Plough, please visit the company's web site at www.schering-plough.com.